0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Lacosamide Oral Solution Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-30X15350
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Lacosamide Oral Solution Market Research Report 2023
BUY CHAPTERS

Global Lacosamide Oral Solution Market Research Report 2025

Code: QYRE-Auto-30X15350
Report
May 2025
Pages:85
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Lacosamide Oral Solution Market

The global market for Lacosamide Oral Solution was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Lacosamide oral solution is indicated in patients 17 years and older with partial-onset seizures as adjunctive therapy. Lacosamide oral solution may be taken with or without food.
North American market for Lacosamide Oral Solution is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Lacosamide Oral Solution is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global manufacturers of Lacosamide Oral Solution include Jiangxi Kerui Pharmaceutical Co., Ltd., China Resources Double-crane Pharmaceutical Co., Ltd., Haida Shehuage Pharmaceutical Co., Ltd., Shanghai Aucta Pharmaceuticals Co., Ltd., Yangtze River Pharmaceutical (Group) Co., Ltd., Shandong Loncom Pharmaceutical Co., Ltd, Jiangxi Qingfeng Pharmaceutical Industry Co., Ltd., UCB Pharma Limited, Glenmark Pharma INC, Vista Pharm INC, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Lacosamide Oral Solution, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lacosamide Oral Solution.
The Lacosamide Oral Solution market size, estimations, and forecasts are provided in terms of sales volume (K Bottles) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Lacosamide Oral Solution market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Lacosamide Oral Solution manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Lacosamide Oral Solution Market Report

Report Metric Details
Report Name Lacosamide Oral Solution Market
Segment by Type
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Jiangxi Kerui Pharmaceutical Co., Ltd., China Resources Double-crane Pharmaceutical Co., Ltd., Haida Shehuage Pharmaceutical Co., Ltd., Shanghai Aucta Pharmaceuticals Co., Ltd., Yangtze River Pharmaceutical (Group) Co., Ltd., Shandong Loncom Pharmaceutical Co., Ltd, Jiangxi Qingfeng Pharmaceutical Industry Co., Ltd., UCB Pharma Limited, Glenmark Pharma INC, Vista Pharm INC
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Lacosamide Oral Solution manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Lacosamide Oral Solution in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Lacosamide Oral Solution Market report?

Ans: The main players in the Lacosamide Oral Solution Market are Jiangxi Kerui Pharmaceutical Co., Ltd., China Resources Double-crane Pharmaceutical Co., Ltd., Haida Shehuage Pharmaceutical Co., Ltd., Shanghai Aucta Pharmaceuticals Co., Ltd., Yangtze River Pharmaceutical (Group) Co., Ltd., Shandong Loncom Pharmaceutical Co., Ltd, Jiangxi Qingfeng Pharmaceutical Industry Co., Ltd., UCB Pharma Limited, Glenmark Pharma INC, Vista Pharm INC

What are the Application segmentation covered in the Lacosamide Oral Solution Market report?

Ans: The Applications covered in the Lacosamide Oral Solution Market report are Hospital, Retail Drug Store, Online Sales, Others

What are the Type segmentation covered in the Lacosamide Oral Solution Market report?

Ans: The Types covered in the Lacosamide Oral Solution Market report are Generic Drug, Original Drug

Recommended Reports

Oral Pharmaceuticals

Antiepileptics & Analgesics

Oral Care & Mucositis

1 Lacosamide Oral Solution Market Overview
1.1 Product Definition
1.2 Lacosamide Oral Solution by Type
1.2.1 Global Lacosamide Oral Solution Market Value Comparison by Type (2024 VS 2031)
1.2.2 Generic Drug
1.2.3 Original Drug
1.3 Lacosamide Oral Solution by Application
1.3.1 Global Lacosamide Oral Solution Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 Retail Drug Store
1.3.4 Online Sales
1.3.5 Others
1.4 Global Lacosamide Oral Solution Market Size Estimates and Forecasts
1.4.1 Global Lacosamide Oral Solution Revenue 2020-2031
1.4.2 Global Lacosamide Oral Solution Sales 2020-2031
1.4.3 Global Lacosamide Oral Solution Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Lacosamide Oral Solution Market Competition by Manufacturers
2.1 Global Lacosamide Oral Solution Sales Market Share by Manufacturers (2020-2025)
2.2 Global Lacosamide Oral Solution Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Lacosamide Oral Solution Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Lacosamide Oral Solution, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Lacosamide Oral Solution, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Lacosamide Oral Solution, Product Type & Application
2.7 Global Key Manufacturers of Lacosamide Oral Solution, Date of Enter into This Industry
2.8 Global Lacosamide Oral Solution Market Competitive Situation and Trends
2.8.1 Global Lacosamide Oral Solution Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Lacosamide Oral Solution Players Market Share by Revenue
2.8.3 Global Lacosamide Oral Solution Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Lacosamide Oral Solution Market Scenario by Region
3.1 Global Lacosamide Oral Solution Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Lacosamide Oral Solution Sales by Region: 2020-2031
3.2.1 Global Lacosamide Oral Solution Sales by Region: 2020-2025
3.2.2 Global Lacosamide Oral Solution Sales by Region: 2026-2031
3.3 Global Lacosamide Oral Solution Revenue by Region: 2020-2031
3.3.1 Global Lacosamide Oral Solution Revenue by Region: 2020-2025
3.3.2 Global Lacosamide Oral Solution Revenue by Region: 2026-2031
3.4 North America Lacosamide Oral Solution Market Facts & Figures by Country
3.4.1 North America Lacosamide Oral Solution Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Lacosamide Oral Solution Sales by Country (2020-2031)
3.4.3 North America Lacosamide Oral Solution Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Lacosamide Oral Solution Market Facts & Figures by Country
3.5.1 Europe Lacosamide Oral Solution Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Lacosamide Oral Solution Sales by Country (2020-2031)
3.5.3 Europe Lacosamide Oral Solution Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Lacosamide Oral Solution Market Facts & Figures by Region
3.6.1 Asia Pacific Lacosamide Oral Solution Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Lacosamide Oral Solution Sales by Region (2020-2031)
3.6.3 Asia Pacific Lacosamide Oral Solution Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Lacosamide Oral Solution Market Facts & Figures by Country
3.7.1 Latin America Lacosamide Oral Solution Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Lacosamide Oral Solution Sales by Country (2020-2031)
3.7.3 Latin America Lacosamide Oral Solution Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Lacosamide Oral Solution Market Facts & Figures by Country
3.8.1 Middle East and Africa Lacosamide Oral Solution Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Lacosamide Oral Solution Sales by Country (2020-2031)
3.8.3 Middle East and Africa Lacosamide Oral Solution Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Lacosamide Oral Solution Sales by Type (2020-2031)
4.1.1 Global Lacosamide Oral Solution Sales by Type (2020-2025)
4.1.2 Global Lacosamide Oral Solution Sales by Type (2026-2031)
4.1.3 Global Lacosamide Oral Solution Sales Market Share by Type (2020-2031)
4.2 Global Lacosamide Oral Solution Revenue by Type (2020-2031)
4.2.1 Global Lacosamide Oral Solution Revenue by Type (2020-2025)
4.2.2 Global Lacosamide Oral Solution Revenue by Type (2026-2031)
4.2.3 Global Lacosamide Oral Solution Revenue Market Share by Type (2020-2031)
4.3 Global Lacosamide Oral Solution Price by Type (2020-2031)
5 Segment by Application
5.1 Global Lacosamide Oral Solution Sales by Application (2020-2031)
5.1.1 Global Lacosamide Oral Solution Sales by Application (2020-2025)
5.1.2 Global Lacosamide Oral Solution Sales by Application (2026-2031)
5.1.3 Global Lacosamide Oral Solution Sales Market Share by Application (2020-2031)
5.2 Global Lacosamide Oral Solution Revenue by Application (2020-2031)
5.2.1 Global Lacosamide Oral Solution Revenue by Application (2020-2025)
5.2.2 Global Lacosamide Oral Solution Revenue by Application (2026-2031)
5.2.3 Global Lacosamide Oral Solution Revenue Market Share by Application (2020-2031)
5.3 Global Lacosamide Oral Solution Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Jiangxi Kerui Pharmaceutical Co., Ltd.
6.1.1 Jiangxi Kerui Pharmaceutical Co., Ltd. Company Information
6.1.2 Jiangxi Kerui Pharmaceutical Co., Ltd. Description and Business Overview
6.1.3 Jiangxi Kerui Pharmaceutical Co., Ltd. Lacosamide Oral Solution Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Jiangxi Kerui Pharmaceutical Co., Ltd. Lacosamide Oral Solution Product Portfolio
6.1.5 Jiangxi Kerui Pharmaceutical Co., Ltd. Recent Developments/Updates
6.2 China Resources Double-crane Pharmaceutical Co., Ltd.
6.2.1 China Resources Double-crane Pharmaceutical Co., Ltd. Company Information
6.2.2 China Resources Double-crane Pharmaceutical Co., Ltd. Description and Business Overview
6.2.3 China Resources Double-crane Pharmaceutical Co., Ltd. Lacosamide Oral Solution Sales, Revenue and Gross Margin (2020-2025)
6.2.4 China Resources Double-crane Pharmaceutical Co., Ltd. Lacosamide Oral Solution Product Portfolio
6.2.5 China Resources Double-crane Pharmaceutical Co., Ltd. Recent Developments/Updates
6.3 Haida Shehuage Pharmaceutical Co., Ltd.
6.3.1 Haida Shehuage Pharmaceutical Co., Ltd. Company Information
6.3.2 Haida Shehuage Pharmaceutical Co., Ltd. Description and Business Overview
6.3.3 Haida Shehuage Pharmaceutical Co., Ltd. Lacosamide Oral Solution Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Haida Shehuage Pharmaceutical Co., Ltd. Lacosamide Oral Solution Product Portfolio
6.3.5 Haida Shehuage Pharmaceutical Co., Ltd. Recent Developments/Updates
6.4 Shanghai Aucta Pharmaceuticals Co., Ltd.
6.4.1 Shanghai Aucta Pharmaceuticals Co., Ltd. Company Information
6.4.2 Shanghai Aucta Pharmaceuticals Co., Ltd. Description and Business Overview
6.4.3 Shanghai Aucta Pharmaceuticals Co., Ltd. Lacosamide Oral Solution Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Shanghai Aucta Pharmaceuticals Co., Ltd. Lacosamide Oral Solution Product Portfolio
6.4.5 Shanghai Aucta Pharmaceuticals Co., Ltd. Recent Developments/Updates
6.5 Yangtze River Pharmaceutical (Group) Co., Ltd.
6.5.1 Yangtze River Pharmaceutical (Group) Co., Ltd. Company Information
6.5.2 Yangtze River Pharmaceutical (Group) Co., Ltd. Description and Business Overview
6.5.3 Yangtze River Pharmaceutical (Group) Co., Ltd. Lacosamide Oral Solution Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Yangtze River Pharmaceutical (Group) Co., Ltd. Lacosamide Oral Solution Product Portfolio
6.5.5 Yangtze River Pharmaceutical (Group) Co., Ltd. Recent Developments/Updates
6.6 Shandong Loncom Pharmaceutical Co., Ltd
6.6.1 Shandong Loncom Pharmaceutical Co., Ltd Company Information
6.6.2 Shandong Loncom Pharmaceutical Co., Ltd Description and Business Overview
6.6.3 Shandong Loncom Pharmaceutical Co., Ltd Lacosamide Oral Solution Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Shandong Loncom Pharmaceutical Co., Ltd Lacosamide Oral Solution Product Portfolio
6.6.5 Shandong Loncom Pharmaceutical Co., Ltd Recent Developments/Updates
6.7 Jiangxi Qingfeng Pharmaceutical Industry Co., Ltd.
6.7.1 Jiangxi Qingfeng Pharmaceutical Industry Co., Ltd. Company Information
6.7.2 Jiangxi Qingfeng Pharmaceutical Industry Co., Ltd. Description and Business Overview
6.7.3 Jiangxi Qingfeng Pharmaceutical Industry Co., Ltd. Lacosamide Oral Solution Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Jiangxi Qingfeng Pharmaceutical Industry Co., Ltd. Lacosamide Oral Solution Product Portfolio
6.7.5 Jiangxi Qingfeng Pharmaceutical Industry Co., Ltd. Recent Developments/Updates
6.8 UCB Pharma Limited
6.8.1 UCB Pharma Limited Company Information
6.8.2 UCB Pharma Limited Description and Business Overview
6.8.3 UCB Pharma Limited Lacosamide Oral Solution Sales, Revenue and Gross Margin (2020-2025)
6.8.4 UCB Pharma Limited Lacosamide Oral Solution Product Portfolio
6.8.5 UCB Pharma Limited Recent Developments/Updates
6.9 Glenmark Pharma INC
6.9.1 Glenmark Pharma INC Company Information
6.9.2 Glenmark Pharma INC Description and Business Overview
6.9.3 Glenmark Pharma INC Lacosamide Oral Solution Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Glenmark Pharma INC Lacosamide Oral Solution Product Portfolio
6.9.5 Glenmark Pharma INC Recent Developments/Updates
6.10 Vista Pharm INC
6.10.1 Vista Pharm INC Company Information
6.10.2 Vista Pharm INC Description and Business Overview
6.10.3 Vista Pharm INC Lacosamide Oral Solution Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Vista Pharm INC Lacosamide Oral Solution Product Portfolio
6.10.5 Vista Pharm INC Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Lacosamide Oral Solution Industry Chain Analysis
7.2 Lacosamide Oral Solution Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Lacosamide Oral Solution Production Mode & Process Analysis
7.4 Lacosamide Oral Solution Sales and Marketing
7.4.1 Lacosamide Oral Solution Sales Channels
7.4.2 Lacosamide Oral Solution Distributors
7.5 Lacosamide Oral Solution Customer Analysis
8 Lacosamide Oral Solution Market Dynamics
8.1 Lacosamide Oral Solution Industry Trends
8.2 Lacosamide Oral Solution Market Drivers
8.3 Lacosamide Oral Solution Market Challenges
8.4 Lacosamide Oral Solution Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Lacosamide Oral Solution Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Lacosamide Oral Solution Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Lacosamide Oral Solution Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Lacosamide Oral Solution Sales (K Bottles) of Key Manufacturers (2020-2025)
 Table 5. Global Lacosamide Oral Solution Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Lacosamide Oral Solution Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Lacosamide Oral Solution Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Lacosamide Oral Solution Average Price (US$/Bottle) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Lacosamide Oral Solution, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Lacosamide Oral Solution, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Lacosamide Oral Solution, Product Type & Application
 Table 12. Global Key Manufacturers of Lacosamide Oral Solution, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Lacosamide Oral Solution by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lacosamide Oral Solution as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Lacosamide Oral Solution Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Lacosamide Oral Solution Sales by Region (2020-2025) & (K Bottles)
 Table 18. Global Lacosamide Oral Solution Sales Market Share by Region (2020-2025)
 Table 19. Global Lacosamide Oral Solution Sales by Region (2026-2031) & (K Bottles)
 Table 20. Global Lacosamide Oral Solution Sales Market Share by Region (2026-2031)
 Table 21. Global Lacosamide Oral Solution Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Lacosamide Oral Solution Revenue Market Share by Region (2020-2025)
 Table 23. Global Lacosamide Oral Solution Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Lacosamide Oral Solution Revenue Market Share by Region (2026-2031)
 Table 25. North America Lacosamide Oral Solution Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Lacosamide Oral Solution Sales by Country (2020-2025) & (K Bottles)
 Table 27. North America Lacosamide Oral Solution Sales by Country (2026-2031) & (K Bottles)
 Table 28. North America Lacosamide Oral Solution Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Lacosamide Oral Solution Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Lacosamide Oral Solution Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Lacosamide Oral Solution Sales by Country (2020-2025) & (K Bottles)
 Table 32. Europe Lacosamide Oral Solution Sales by Country (2026-2031) & (K Bottles)
 Table 33. Europe Lacosamide Oral Solution Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Lacosamide Oral Solution Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Lacosamide Oral Solution Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Lacosamide Oral Solution Sales by Region (2020-2025) & (K Bottles)
 Table 37. Asia Pacific Lacosamide Oral Solution Sales by Region (2026-2031) & (K Bottles)
 Table 38. Asia Pacific Lacosamide Oral Solution Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Lacosamide Oral Solution Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Lacosamide Oral Solution Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Lacosamide Oral Solution Sales by Country (2020-2025) & (K Bottles)
 Table 42. Latin America Lacosamide Oral Solution Sales by Country (2026-2031) & (K Bottles)
 Table 43. Latin America Lacosamide Oral Solution Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Lacosamide Oral Solution Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Lacosamide Oral Solution Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Lacosamide Oral Solution Sales by Country (2020-2025) & (K Bottles)
 Table 47. Middle East and Africa Lacosamide Oral Solution Sales by Country (2026-2031) & (K Bottles)
 Table 48. Middle East and Africa Lacosamide Oral Solution Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Lacosamide Oral Solution Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Lacosamide Oral Solution Sales (K Bottles) by Type (2020-2025)
 Table 51. Global Lacosamide Oral Solution Sales (K Bottles) by Type (2026-2031)
 Table 52. Global Lacosamide Oral Solution Sales Market Share by Type (2020-2025)
 Table 53. Global Lacosamide Oral Solution Sales Market Share by Type (2026-2031)
 Table 54. Global Lacosamide Oral Solution Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Lacosamide Oral Solution Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Lacosamide Oral Solution Revenue Market Share by Type (2020-2025)
 Table 57. Global Lacosamide Oral Solution Revenue Market Share by Type (2026-2031)
 Table 58. Global Lacosamide Oral Solution Price (US$/Bottle) by Type (2020-2025)
 Table 59. Global Lacosamide Oral Solution Price (US$/Bottle) by Type (2026-2031)
 Table 60. Global Lacosamide Oral Solution Sales (K Bottles) by Application (2020-2025)
 Table 61. Global Lacosamide Oral Solution Sales (K Bottles) by Application (2026-2031)
 Table 62. Global Lacosamide Oral Solution Sales Market Share by Application (2020-2025)
 Table 63. Global Lacosamide Oral Solution Sales Market Share by Application (2026-2031)
 Table 64. Global Lacosamide Oral Solution Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Lacosamide Oral Solution Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Lacosamide Oral Solution Revenue Market Share by Application (2020-2025)
 Table 67. Global Lacosamide Oral Solution Revenue Market Share by Application (2026-2031)
 Table 68. Global Lacosamide Oral Solution Price (US$/Bottle) by Application (2020-2025)
 Table 69. Global Lacosamide Oral Solution Price (US$/Bottle) by Application (2026-2031)
 Table 70. Jiangxi Kerui Pharmaceutical Co., Ltd. Company Information
 Table 71. Jiangxi Kerui Pharmaceutical Co., Ltd. Description and Business Overview
 Table 72. Jiangxi Kerui Pharmaceutical Co., Ltd. Lacosamide Oral Solution Sales (K Bottles), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2020-2025)
 Table 73. Jiangxi Kerui Pharmaceutical Co., Ltd. Lacosamide Oral Solution Product
 Table 74. Jiangxi Kerui Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 75. China Resources Double-crane Pharmaceutical Co., Ltd. Company Information
 Table 76. China Resources Double-crane Pharmaceutical Co., Ltd. Description and Business Overview
 Table 77. China Resources Double-crane Pharmaceutical Co., Ltd. Lacosamide Oral Solution Sales (K Bottles), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2020-2025)
 Table 78. China Resources Double-crane Pharmaceutical Co., Ltd. Lacosamide Oral Solution Product
 Table 79. China Resources Double-crane Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 80. Haida Shehuage Pharmaceutical Co., Ltd. Company Information
 Table 81. Haida Shehuage Pharmaceutical Co., Ltd. Description and Business Overview
 Table 82. Haida Shehuage Pharmaceutical Co., Ltd. Lacosamide Oral Solution Sales (K Bottles), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2020-2025)
 Table 83. Haida Shehuage Pharmaceutical Co., Ltd. Lacosamide Oral Solution Product
 Table 84. Haida Shehuage Pharmaceutical Co., Ltd. Recent Developments/Updates
 Table 85. Shanghai Aucta Pharmaceuticals Co., Ltd. Company Information
 Table 86. Shanghai Aucta Pharmaceuticals Co., Ltd. Description and Business Overview
 Table 87. Shanghai Aucta Pharmaceuticals Co., Ltd. Lacosamide Oral Solution Sales (K Bottles), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2020-2025)
 Table 88. Shanghai Aucta Pharmaceuticals Co., Ltd. Lacosamide Oral Solution Product
 Table 89. Shanghai Aucta Pharmaceuticals Co., Ltd. Recent Developments/Updates
 Table 90. Yangtze River Pharmaceutical (Group) Co., Ltd. Company Information
 Table 91. Yangtze River Pharmaceutical (Group) Co., Ltd. Description and Business Overview
 Table 92. Yangtze River Pharmaceutical (Group) Co., Ltd. Lacosamide Oral Solution Sales (K Bottles), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2020-2025)
 Table 93. Yangtze River Pharmaceutical (Group) Co., Ltd. Lacosamide Oral Solution Product
 Table 94. Yangtze River Pharmaceutical (Group) Co., Ltd. Recent Developments/Updates
 Table 95. Shandong Loncom Pharmaceutical Co., Ltd Company Information
 Table 96. Shandong Loncom Pharmaceutical Co., Ltd Description and Business Overview
 Table 97. Shandong Loncom Pharmaceutical Co., Ltd Lacosamide Oral Solution Sales (K Bottles), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2020-2025)
 Table 98. Shandong Loncom Pharmaceutical Co., Ltd Lacosamide Oral Solution Product
 Table 99. Shandong Loncom Pharmaceutical Co., Ltd Recent Developments/Updates
 Table 100. Jiangxi Qingfeng Pharmaceutical Industry Co., Ltd. Company Information
 Table 101. Jiangxi Qingfeng Pharmaceutical Industry Co., Ltd. Description and Business Overview
 Table 102. Jiangxi Qingfeng Pharmaceutical Industry Co., Ltd. Lacosamide Oral Solution Sales (K Bottles), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2020-2025)
 Table 103. Jiangxi Qingfeng Pharmaceutical Industry Co., Ltd. Lacosamide Oral Solution Product
 Table 104. Jiangxi Qingfeng Pharmaceutical Industry Co., Ltd. Recent Developments/Updates
 Table 105. UCB Pharma Limited Company Information
 Table 106. UCB Pharma Limited Description and Business Overview
 Table 107. UCB Pharma Limited Lacosamide Oral Solution Sales (K Bottles), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2020-2025)
 Table 108. UCB Pharma Limited Lacosamide Oral Solution Product
 Table 109. UCB Pharma Limited Recent Developments/Updates
 Table 110. Glenmark Pharma INC Company Information
 Table 111. Glenmark Pharma INC Description and Business Overview
 Table 112. Glenmark Pharma INC Lacosamide Oral Solution Sales (K Bottles), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2020-2025)
 Table 113. Glenmark Pharma INC Lacosamide Oral Solution Product
 Table 114. Glenmark Pharma INC Recent Developments/Updates
 Table 115. Vista Pharm INC Company Information
 Table 116. Vista Pharm INC Description and Business Overview
 Table 117. Vista Pharm INC Lacosamide Oral Solution Sales (K Bottles), Revenue (US$ Million), Price (US$/Bottle) and Gross Margin (2020-2025)
 Table 118. Vista Pharm INC Lacosamide Oral Solution Product
 Table 119. Vista Pharm INC Recent Developments/Updates
 Table 120. Key Raw Materials Lists
 Table 121. Raw Materials Key Suppliers Lists
 Table 122. Lacosamide Oral Solution Distributors List
 Table 123. Lacosamide Oral Solution Customers List
 Table 124. Lacosamide Oral Solution Market Trends
 Table 125. Lacosamide Oral Solution Market Drivers
 Table 126. Lacosamide Oral Solution Market Challenges
 Table 127. Lacosamide Oral Solution Market Restraints
 Table 128. Research Programs/Design for This Report
 Table 129. Key Data Information from Secondary Sources
 Table 130. Key Data Information from Primary Sources
 Table 131. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Lacosamide Oral Solution
 Figure 2. Global Lacosamide Oral Solution Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Lacosamide Oral Solution Market Share by Type: 2024 & 2031
 Figure 4. Generic Drug Product Picture
 Figure 5. Original Drug Product Picture
 Figure 6. Global Lacosamide Oral Solution Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Lacosamide Oral Solution Market Share by Application: 2024 & 2031
 Figure 8. Hospital
 Figure 9. Retail Drug Store
 Figure 10. Online Sales
 Figure 11. Others
 Figure 12. Global Lacosamide Oral Solution Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Lacosamide Oral Solution Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Lacosamide Oral Solution Sales (2020-2031) & (K Bottles)
 Figure 15. Global Lacosamide Oral Solution Average Price (US$/Bottle) & (2020-2031)
 Figure 16. Lacosamide Oral Solution Report Years Considered
 Figure 17. Lacosamide Oral Solution Sales Share by Manufacturers in 2024
 Figure 18. Global Lacosamide Oral Solution Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Lacosamide Oral Solution Players: Market Share by Revenue in Lacosamide Oral Solution in 2024
 Figure 20. Lacosamide Oral Solution Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Lacosamide Oral Solution Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Lacosamide Oral Solution Sales Market Share by Country (2020-2031)
 Figure 23. North America Lacosamide Oral Solution Revenue Market Share by Country (2020-2031)
 Figure 24. United States Lacosamide Oral Solution Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Lacosamide Oral Solution Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Lacosamide Oral Solution Sales Market Share by Country (2020-2031)
 Figure 27. Europe Lacosamide Oral Solution Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Lacosamide Oral Solution Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Lacosamide Oral Solution Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Lacosamide Oral Solution Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Lacosamide Oral Solution Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Lacosamide Oral Solution Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Lacosamide Oral Solution Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Lacosamide Oral Solution Revenue Market Share by Region (2020-2031)
 Figure 35. China Lacosamide Oral Solution Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Lacosamide Oral Solution Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Lacosamide Oral Solution Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Lacosamide Oral Solution Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Lacosamide Oral Solution Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. China Taiwan Lacosamide Oral Solution Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Southeast Asia Lacosamide Oral Solution Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Latin America Lacosamide Oral Solution Sales Market Share by Country (2020-2031)
 Figure 43. Latin America Lacosamide Oral Solution Revenue Market Share by Country (2020-2031)
 Figure 44. Mexico Lacosamide Oral Solution Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Brazil Lacosamide Oral Solution Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Argentina Lacosamide Oral Solution Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Middle East and Africa Lacosamide Oral Solution Sales Market Share by Country (2020-2031)
 Figure 48. Middle East and Africa Lacosamide Oral Solution Revenue Market Share by Country (2020-2031)
 Figure 49. Turkey Lacosamide Oral Solution Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Saudi Arabia Lacosamide Oral Solution Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. UAE Lacosamide Oral Solution Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Global Sales Market Share of Lacosamide Oral Solution by Type (2020-2031)
 Figure 53. Global Revenue Market Share of Lacosamide Oral Solution by Type (2020-2031)
 Figure 54. Global Lacosamide Oral Solution Price (US$/Bottle) by Type (2020-2031)
 Figure 55. Global Sales Market Share of Lacosamide Oral Solution by Application (2020-2031)
 Figure 56. Global Revenue Market Share of Lacosamide Oral Solution by Application (2020-2031)
 Figure 57. Global Lacosamide Oral Solution Price (US$/Bottle) by Application (2020-2031)
 Figure 58. Lacosamide Oral Solution Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Strategic Venue Partners

SIMILAR REPORTS